rs3218673
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP2_StrongBP4BA1
This summary comes from the ClinGen Evidence Repository: The ATM c.2614C>T (p.Pro872Ser) variant has a GnomAD FAF 4.6% (AFR) exceeding ATM BA1 threshold of .5% (BA1). This variant has been observed in a homozygous or compound heterozygous state (presumed and/or confirmed) in multiple individuals without Ataxia-Telangiectasia (BP2_Strong, Clinical Diagnostic Laboratories). This variant is predicted tolerated by multiple protein in silico tools (BP4). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the HBOP Variant Curation Expert Panel. LINK:https://erepo.genome.network/evrepo/ui/classification/CA157083/MONDO:0016419/020
Frequency
Consequence
NM_000051.4 missense
Scores
Clinical Significance
Conservation
Publications
- ATM-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- ataxia telangiectasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- gastric carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATM | MANE Select | c.2614C>T | p.Pro872Ser | missense | Exon 17 of 63 | ENSP00000501606.1 | Q13315 | ||
| ATM | TSL:1 | c.2614C>T | p.Pro872Ser | missense | Exon 18 of 64 | ENSP00000388058.2 | Q13315 | ||
| ATM | TSL:1 | c.2614C>T | p.Pro872Ser | missense | Exon 17 of 30 | ENSP00000434327.3 | H0YDU7 |
Frequencies
GnomAD3 genomes AF: 0.0128 AC: 1946AN: 152006Hom.: 53 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00353 AC: 888AN: 251426 AF XY: 0.00251 show subpopulations
GnomAD4 exome AF: 0.00133 AC: 1943AN: 1461778Hom.: 39 Cov.: 31 AF XY: 0.00118 AC XY: 861AN XY: 727190 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0128 AC: 1953AN: 152126Hom.: 53 Cov.: 32 AF XY: 0.0117 AC XY: 873AN XY: 74378 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at